Bapcor’s analyst price target has been reset sharply from A$3.21 to A$0.97. This move materially changes the valuation anchor ...
SANUWAVE Health’s revised price target, now reduced by $6, has sharpened the focus on what analysts see as a more cautious ...
Target faced significant sales and reputation declines after rolling back DEI policies and controversial Pride Month displays, leading to widespread boycotts and a 30% stock drop. However, RepTrak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results